14-3-3 Zeta and tau genes interactively decrease Alzheimer's disease risk

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 4, 2008, Pages 317-320

  Mateo, Ignacio ^a   Sánchez Juan, Pascual ^a   Rodríguez Rodríguez, Eloy ^a   Infante, Jon ^a   Fernández Viadero, Carlos ^b   Peña, Nicolás ^b   Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Institute for Formation and Research of the Foundation 'Marqués de Valdecilla' ^*  (Spain)

Author keywords

14 3 3 zeta; Alzheimer's disease; Epistasis; Gene polymorphism; Tau

Indexed keywords

PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; MALE; MIDDLE AGED; ODDS RATIO; PHOSPHORYLATION; POLYMORPHISM, GENETIC; RISK FACTORS; TAU PROTEINS;

EID: 42449119801     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119123     Document Type: Article

References (13)

1. Wang JZ, Grundke-Iqbal I, Iqbal K: Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 2007;25:59-68.
2. Berg D, Holzmann C, Riess O: 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003;4:752-762.
3. Hashiguchi M, Sobue K, Paudel HK: 14-3-3 zeta is an effector of tau protein phosphorylation. J Biol Chem 2000;275:25247-25254.
4. Agarwal-Mawal A, Qureshi HY, Cafferty PW, Yuan Z, Han D, Lin R, Paudel HK: 14-3-3 connects glycogen syntase kinase-3β to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 2003;278:12722-12728.
5. Soulié C, Nicole A, Delacourte A, Ceballos-Picot I: Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process. Neurosci Lett 2004;365:1-5.
6. Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ: Neurofibrillary tangles of Alzheimer's disease brains contains 14-3-3 proteins. Neurosci Lett 1996;209:57-60.
7. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T, Ikeda K, Takasaki M: 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol 2004;108:279-286.
8. Jia Y, Yu X, Zhang B, Yuan Y, Xu Q, Shen Y, Shen Y: An association study between polymorphisms in three genes of 14-3-3 (tyrosine 3-monooxygenase/ tryptophan 5-monooxygenase activation protein) family and paranoid schizophrenia in northern Chinese population. Eur Psychiatry 2004;19:377-379.
9. Myers AJ, Kaleem M, Marlowe L, Pittman AM, Lees AJ, Fung HC, Duckworth J, Leung D, Gibson A, Morris CM, de Silva R, Hardy J: The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet 2005;14:2399-2404.
10. McKhaan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDA-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:934-944.
11. Mukherjee O, Kauwe JSK, Mayo K, Morris JC, Goate AM: Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. BMC Genetics 2007;8:3.
12. Myers AJ, Pittman AM, Zhao AD, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J: The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 2007;25:561-570.
13. Wong AHC, Likhodi O, Trakalo J, Yusuf M, Sinha A, Pato CN, Pato MT, Van Tol HHM, Kennedy JL: Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. Schizophr Res 2005;78:137-146.